(12) Patent Application Publication (10) Pub. No.: US 2015/0010526 A1 Liu Et Al

(12) Patent Application Publication (10) Pub. No.: US 2015/0010526 A1 Liu Et Al

US 2015 0010526A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2015/0010526 A1 Liu et al. (43) Pub. Date: Jan. 8, 2015 (54) EVALUATION AND IMPROVEMENT OF (52) U.S. Cl. NUCLEASE CLEAVAGE SPECIFICITY CPC ................ CI2N 9/22 (2013.01); C12O I/6874 (2013.01); C12O I/44 (2013.01) (71) Applicant: President and Fellows of Harvard USPC ............................................ 424/94.61; 506/2 College, Cambridge, MA (US) (72) Inventors: David R. Liu, Lexington, MA (US); John Paul Guilinger, Ridgway, CO (57) ABSTRACT (US); Vikram Pattanayak, Cambridge, MA (US) Engineered nucleases (e.g., Zinc finger nucleases (ZFNs). (73) Assignee: President and Fellows of Harvard transcriptional activator-like effector nucleases (TALENs). College, Cambridge, MA (US) and others) are promising tools for genome manipulation and determining off-target cleavage sites of these enzymes is of (21) Appl. No.: 14/320,271 great interest. We developed an in vitro selection method that interrogates 10' DNA sequences for their ability to be (22) Filed: Jun. 30, 2014 cleaved by active, dimeric nulceases, e.g., ZFNs and TAL O O ENs. The method revealed hundreds of thousands of DNA Related U.S. Application Data sequences, some present in the human genome, that can be (63) Continuation of application No. 14/234,031, filed on cleaved in vitro by two ZFNs, CCR5-224 and VF2468, which Mar. 24, 2014, filed as application No. PCT/US2012/ target the endogenous human CCR5 and VEGF-A genes, 047778 on Jul 22, 2012. respectively. Analysis of the identified sites in cultured (60) Provisional application No. 61/510.841, filed on Jul. human cells revealed CCR5-224-induced mutagenesis at 22, 2011. nine off-target loci. Similarly, we observed 31 off-target sites s cleaved by VF2468 in cultured human cells. Our findings Publication Classification establish an energy compensation model of ZFN specificity in which excess binding energy contributes to off-target ZFN (51) Int. Cl. cleavage and suggest strategies for the improvement of future CI2N 9/22 (2006.01) nuclease design. It was also pobserved that TALENs can CI2O I/44 (2006.01) achieve cleavage specificity similar to or higher than that CI2O I/68 (2006.01) observed in ZFNs. Patent Application Publication Jan. 8, 2015 Sheet 1 of 67 US 201S/0010526 A1 S R S R 5' overhang fill-i 3 dA addition sequence adapter ligation 8888. SR 888 S Patent Application Publication Jan. 8, 2015 Sheet 2 of 67 US 201S/0010526 A1 specificity SCBE {} ,3 6 N G A T G A G G A T G A C N CCR3-224 (-) N A A A c T G c A A A A. G. N. Fig. 2A specificity Sissa WF2468 (+) N G A G T G A G G A N WF2468 (-) Patent Application Publication Jan. 8, 2015 Sheet 3 of 67 US 201S/0010526 A1 CR5-224 (+) site (-) site T C A T C C T C A T C spacer A A A C T G C A A A A G 3. - O - 8 -3.8 - 4 - 2 , 4. ,6 ,8 A specificity score Fig. 3A Patent Application Publication Jan. 8, 2015 Sheet 4 of 67 US 201S/0010526 A1 WF2A68 (--) site {-} site 5' C C C A C T C spacer G A C G C T G C 3' - O -0.8 -3.8 -.4 -0. 8.4 0.6 .8 A specificity score Fig. 3B Patent Application Publication Jan. 8, 2015 Sheet 5 of 67 US 201S/0010526 A1 {RS-234 3 station s O 9.6 - 3 titations 3 titations 4 2, 8.5 enzyme concentration in selection Fig. 4A WF468 (3% 9% 8% 7% 6% S% & statio: 4% E3 2 ?itatios 3% 3rritatics % - % 4. W 2 ry 1 nM 0.5 nM enzyme concertation in selection Fig. 4B Patent Application Publication Jan. 8, 2015 Sheet 6 of 67 US 201S/0010526 A1 *------------------------------------ Ägand#36 G-61-I Patent Application Publication Jan. 8, 2015 Sheet 7 of 67 US 201S/0010526 A1 FAG-8A standard (ng) ----------------------------------------------------4 8 12 16 20 24 . if f N. N. S S & & (ii is is is its S S C ; S.S. SoS. C a e - se 3. ww. s Fig.6A Fig.6B 43 350 : 300 3. ... 253– 15 S 300 g 150 ... Co- 0 AG Standacis 58- - AFNs - linea (FAG standards) {} } C 5 2 RS 3. rig of protei Fig. 6C Patent Application Publication Jan. 8, 2015 Sheet 8 of 67 US 201S/0010526 A1 Fig. 6D Patent Application Publication Jan. 8, 2015 Sheet 9 of 67 US 201S/0010526 A1 CRS-24 i : Fig. 7A W468 --- ke aa s s Fi 9. B Patent Application Publication Jan. 8, 2015 Sheet 10 of 67 US 2015/0010526A1 3 5 --- aw t 3 O / A\- -(- pre-Selection / /\,\, - - - - - - 4 y 2S ~A-2 ry --X - y O - K - 0.5 nM s O 2 3. 4. s 6 7 8 9 O. nun be of utations Fig. 8A -- pre-Selection ------ 4 ny - A-. nw --X - -k- (.5 v number of mutations Fig. 8B Patent Application Publication Jan. 8, 2015 Sheet 12 of 67 US 2015/0010526A1 CCR5-224 (--), 4 nM specificity SQ8 N GC. A G 3' CCR5-224 (--), M N A Arc A A C N Fig. 10A Patent Application Publication Jan. 8, 2015 Sheet 13 of 67 US 2015/0010526A1 CCR5-224 (-) S specificity SCCE N A A A C T G C A A A A G N CCFS-224 (-), M in A A Act g c A A A A G n CCR5-224 (-), 0.5 riv N A A A C T G C A A A A G N, Fig. 10B Patent Application Publication Jan. 8, 2015 Sheet 14 of 67 US 2015/0010526A1 WF2468 (--), 4 nM specificity SCO3 S WF2468 (--), 0.5 nM S’ 3. Patent Application Publication Jan. 8, 2015 Sheet 15 of 67 US 2015/0010526A1 specificity SCO8 C C G C N WF2468 (-), 0.5 nM A C C C G Fig. 10D Patent Application Publication Jan. 8, 2015 Sheet 16 of 67 US 201S/0010526 A1 Patent Application Publication Jan. 8, 2015 Sheet 17 of 67 US 201S/0010526 A1 Nºvv_2P_1>v_v_v_N" 5 - K. ovb1p9 - O - 4 Patent Application Publication Jan. 8, 2015 Sheet 18 of 67 US 201S/0010526 A1 ? Patent Application Publication Jan. 8, 2015 Sheet 19 of 67 US 2015/0010526A1 WF2468 (--), 4 nM WF2468 (-), 4 nM G C A s N specificity WF2468 (--), when f2468 (-), whes (3-3G is fatated s T G G : C C A : A N G A G T G A G G A N. N G A C G C T G C T N. WF2463 (+), when {-}{ is nutated VF2468 (-), when {-}G is mutated x f x C C A A. N 5' s S 3' WF2468 (+), WF2468 (-), wher. --G and {-}G are notated when {{-}G and (-)G are nutated & are erger N G A G T G A G G A N, S 3 Fig. 13 Patent Application Publication Jan. 8, 2015 Sheet 20 of 67 US 2015/0010526A1 3. s ; : is a is is a & a 2. 22 2.wo a.a. F. a 2. s 2 : a 2.2 S 2 : a 2 w s a 2. 2. 8 . (- - a. c. - - 8. s ; : a ; : ee a a - - c tr i. i. if awww.www.www.www.www. 22 P ef s r is 2 : 22. e a 2. s a 2. s 22 s a a r R na n O a 2 a a i 3 w a a a 2. a ................ 5. d. ... c. c. 8 B 3 S. a a Ei & 2 2. 22. es 2 : s 22re &s isna a 2. 2 : a 2. 2. ' a 2 : a 2. a 2. w 2 2 w it. ... ... - - . ... Patent Application Publication Jan. 8, 2015 Sheet 21 of 67 US 2015/0010526A1 s: a s a i. is 3 a 2. 2. a. 2 : iss ? Ss a a 2 2 a 2 : ...Y 2. wat a 22. ... - a. c. ... - -, is. a. : & iss ; : s:s i. 2, ase Ca 22. 2 s s 2 : a m s e e 22 s 2 2. s a a : 3 ra. O e a a sess e - 22 a la a a 2. at a 3. A- A. a. c. C. C.- 3. - - i.- i. ;- : a E. is ; : Ea a 2. 2 s fi- fif , , , , , tea 2 : Ya. - 2. ra 2 : ran 2. 2. a 2 : a 2 : a 2 2. a 2. 22 2. Aw C. C. i. e. - C. h. Patent Application Publication Jan. 8, 2015 Sheet 22 of 67 US 201S/0010526 A1 O% 45% si. 35% CCR5-224, , , 3% 7 5% 20% 3 6 S. S 5 O% 3. ce S96 Q 4 4 5 6 7 spacer ength Fig. 15A CCRS-224, 7 is 6 - s to a 5 6 spacer lengt; Fig. 15B Patent Application Publication Jan. 8, 2015 Sheet 23 of 67 US 2015/0010526A1 CCR5-224, 2 7 3 & 5. s . S. O a s 6 Spacer ength Fig. 15C CCR5-224, 4 5. s 6 5 to spacer length Fig. 15D Patent Application Publication Jan. 8, 2015 Sheet 24 of 67 US 2015/0010526A1 WF2468, O.S. -- :-- 7 s s . c s C sa > & spacer length Fig. 16A WF2468, in 67 s 4. spacer length Fig. 16B Patent Application Publication Jan. 8, 2015 Sheet 25 of 67 US 2015/0010526A1 WF2468, 7 6 ma 4. A. S 6 7 O% Spacer ength Fig. 16C 5% AS.6 a0% 3596. WF468, 4 ti 3% 2% O% 56f --ra S96 O% 4.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    158 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us